Ligthspeed Venture Partners

Forty Seven Inc Raised $75 Million to Develop Antibodies for Cancer

The Series A round was announced on Wednesday. The company has also licensed the rights for multiple immuno-oncology programs from Stanford University.

Read Full Article

Subscribe to VCpost newsletter

Sign up for our Deals of the Day newsletter.
We will not spam you!

Real Time Analytics